1. Home
  2. TXG vs DCO Comparison

TXG vs DCO Comparison

Compare TXG & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • DCO
  • Stock Information
  • Founded
  • TXG 2012
  • DCO 1849
  • Country
  • TXG United States
  • DCO United States
  • Employees
  • TXG N/A
  • DCO N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • DCO Military/Government/Technical
  • Sector
  • TXG Industrials
  • DCO Industrials
  • Exchange
  • TXG Nasdaq
  • DCO Nasdaq
  • Market Cap
  • TXG 1.6B
  • DCO 1.4B
  • IPO Year
  • TXG 2019
  • DCO N/A
  • Fundamental
  • Price
  • TXG $15.76
  • DCO $88.88
  • Analyst Decision
  • TXG Buy
  • DCO Strong Buy
  • Analyst Count
  • TXG 13
  • DCO 4
  • Target Price
  • TXG $14.50
  • DCO $119.75
  • AVG Volume (30 Days)
  • TXG 3.1M
  • DCO 154.8K
  • Earning Date
  • TXG 11-06-2025
  • DCO 11-06-2025
  • Dividend Yield
  • TXG N/A
  • DCO N/A
  • EPS Growth
  • TXG N/A
  • DCO N/A
  • EPS
  • TXG N/A
  • DCO N/A
  • Revenue
  • TXG $641,814,000.00
  • DCO $806,224,000.00
  • Revenue This Year
  • TXG $2.07
  • DCO $6.20
  • Revenue Next Year
  • TXG N/A
  • DCO $8.26
  • P/E Ratio
  • TXG N/A
  • DCO N/A
  • Revenue Growth
  • TXG 1.92
  • DCO 3.17
  • 52 Week Low
  • TXG $6.78
  • DCO $51.76
  • 52 Week High
  • TXG $17.70
  • DCO $101.47
  • Technical
  • Relative Strength Index (RSI)
  • TXG 61.04
  • DCO 41.52
  • Support Level
  • TXG $15.12
  • DCO $87.24
  • Resistance Level
  • TXG $17.70
  • DCO $99.78
  • Average True Range (ATR)
  • TXG 1.01
  • DCO 3.20
  • MACD
  • TXG 0.22
  • DCO -0.35
  • Stochastic Oscillator
  • TXG 64.37
  • DCO 13.40

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: